Literature DB >> 16218508

An update on the impact of Staphylococcus aureus enterotoxins in chronic sinusitis with nasal polyposis.

N Zhang1, P Gevaert, T van Zele, C Perez-Novo, J Patou, G Holtappels, P van Cauwenberge, C Bachert.   

Abstract

Nasal polyps in adults, characterized by abundant eosinophils, local overproduction of immunoglobulin E, and often associated with asthma, have been appreciated as an eosinophilic inflammation, potentially of allergic origin, but unrelated to a bacterial impact. Evidence accumulates, however, that Staphylococcus aureus colonizes chronic rhinosinusitis with, but not without polyps, with significantly increased prevalence. The germs release enterotoxins, which act as superantigens and induce a topical multiclonal IgE-formation as well as a severe, possibly steroid-insensitive eosinophilic inflammation. Recently, S. aureus could be demonstrated to reside intraepithelially, and potentially to release superantigens into the tissue from within the epithelial cells. An immune defect, either in the innate or adaptive immunity, might be responsible for this phenomenon. Follicle-like structures and lymphocyte accumulations, specifically binding enterotoxins, can be found within the polyp tissues, giving rise to local IgE formation. The superantigen-induced immune response also leads to a modulation of the severity of the eosinophilic inflammation, and may be linked to lower airway co-morbidity in polyp patients. Interestingly, IgE antibodies to enterotoxins can be found in the majority of aspirin-sensitive polyp tissues, associated with a substantial increase in ECP and IL-5. The possible role of S. aureus enterotoxins in polyp disease in Europe, the US and Asia has meanwhile been supported by several studies, demonstrating the presence of IgE antibodies to enterotoxins and inflammatory consequences in nasal polyp tissue. First studies also point to an involvement of S. aureus derived enterotoxins in lower airway disease, such as severe asthma and exacerbated COPD, clearly suggesting a clinical need for diagnosis and treatment of the germ and its related effects. Therapeutic approaches are so far empirical, and need further study, also serving to proof the clinical relevance of the concept.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16218508

Source DB:  PubMed          Journal:  Rhinology        ISSN: 0300-0729            Impact factor:   3.681


  28 in total

1.  [Rhinosinusitis guidelines--unabridged version: S2 guidelines from the German Society of Otorhinolaryngology, Head and Neck Surgery].

Authors:  B A Stuck; C Bachert; P Federspil; W Hosemann; L Klimek; R Mösges; O Pfaar; C Rudack; H Sitter; M Wagenmann; R Weber; K Hörmann
Journal:  HNO       Date:  2012-02       Impact factor: 1.284

2.  [Rhinosinusitis guidelines of the German Society for Otorhinolaryngology, Head and Neck Surgery].

Authors:  B A Stuck; C Bachert; P Federspil; W Hosemann; L Klimek; R Mösges; O Pfaar; C Rudack; H Sitter; M Wagenmann; K Hörmann
Journal:  HNO       Date:  2007-10       Impact factor: 1.284

3.  Induction of CXC chemokines in A549 airway epithelial cells by trypsin and staphylococcal proteases - a possible route for neutrophilic inflammation in chronic rhinosinusitis.

Authors:  F Sachse; C von Eiff; W Stoll; K Becker; C Rudack
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

Review 4.  The Role of Staphylococcus aureus in Patients with Chronic Sinusitis and Nasal Polyposis.

Authors:  Thad W Vickery; Vijay R Ramakrishnan; Jeffrey D Suh
Journal:  Curr Allergy Asthma Rep       Date:  2019-03-11       Impact factor: 4.806

5.  Increased risk of psoriasis in patients with chronic rhinosinusitis without nasal polyps: a longitudinal follow-up study using Korean national sample cohort.

Authors:  Hyo Geun Choi; Ho Jun Lee
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-07-27       Impact factor: 2.503

6.  Intranasal exposure to bacterial superantigens induces airway inflammation in HLA class II transgenic mice.

Authors:  Govindarajan Rajagopalan; Koji Iijima; Manisha Singh; Hirohito Kita; Robin Patel; Chella S David
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

7.  Role of tissue eosinophils in chronic rhinosinusitis-associated olfactory loss.

Authors:  Leah J Hauser; Rakesh K Chandra; Ping Li; Justin H Turner
Journal:  Int Forum Allergy Rhinol       Date:  2017-07-25       Impact factor: 3.858

8.  The significance of osteitis in rhinosinusitis.

Authors:  Neeraj Sethi
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-04-27       Impact factor: 2.503

Review 9.  Perspectives on the etiology of chronic rhinosinusitis: an immune barrier hypothesis.

Authors:  Robert C Kern; David B Conley; William Walsh; Rakesh Chandra; Atsushi Kato; Anju Tripathi-Peters; Leslie C Grammer; Robert P Schleimer
Journal:  Am J Rhinol       Date:  2008-09-10

Review 10.  Beyond inflammation: airway epithelial cells are at the interface of innate and adaptive immunity.

Authors:  Atsushi Kato; Robert P Schleimer
Journal:  Curr Opin Immunol       Date:  2007-10-24       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.